Table 3.
HER2-Positive/TN (N = 82) | Luminal (N = 38) | |||
---|---|---|---|---|
pCR (N = 22) | Residual Tumor (N = 60) |
pCR (N = 0) | Residual Tumor (N = 38) |
|
MTVcsc < 1.75 cm3 | 22 | 21 | 0 | 27 |
MTVcsc > 1.75 cm3 | 0 | 39 | 0 | 11 |
Prediction accuracy | 74% (61/82) | 29% (11/38) |
HER2-Positive/TN (N = 82) | Luminal (N = 38) | |||
---|---|---|---|---|
pCR (N = 22) | Residual Tumor (N = 60) |
pCR (N = 0) | Residual Tumor (N = 38) |
|
MTVcsc < 1.75 cm3 | 22 | 21 | 0 | 27 |
MTVcsc > 1.75 cm3 | 0 | 39 | 0 | 11 |
Prediction accuracy | 74% (61/82) | 29% (11/38) |